Delivery Order SPE2DB20D1109-SPE2DB21FP97S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of MICROGESTIN FE 1-20 TABLET 28S. The contract has a ceiling value of $1,159.34 and an ultimate completion date of December 1, 2023. This is a Firm Fixed Price Delivery Order contract, and there was no set-aside used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3MTS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, with a ceiling value of $4,245.19 and a completion date of November 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,887.44 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The award is not associated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency (DLA) is for the delivery of pharmaceutical products, including Microgestin FE 1-20 tablets, with a ceiling value of $1,929.72. The contract is a firm fixed-price Delivery Order with a completion date of December 22, 2021. This award is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen maintains a significant Indefinite...
- This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,288.48 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2021, with a completion date of November 17, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.47, is for the delivery of Microgestin FE 1.5-30 tablets (28s). The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,674.45 firm-fixed-price delivery order is for the pharmaceutical product MICROGESTIN FE 1.5-30 TAB 28S. There was no set-aside used for this award. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,305.90 firm-fixed-price delivery order is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription medication. The contract award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.42 firm-fixed-price delivery order covers the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which enables the company to...
- This federal contract award, valued at $1,139.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 5, 2025. The contract covers the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FP97SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,346.28, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 10, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/9/21 |